Literature DB >> 11408616

Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes.

L Ferrari1, N Peng, J R Halpert, E T Morgan.   

Abstract

There are conflicting reports about the role of nitric oxide in the down-regulation of cytochrome P450 that occurs when animals or cultured hepatocytes are exposed to inflammatory stimuli. Here, we investigated the participation of NO in the down-regulation of CYP2B1 by bacterial endotoxin (LPS) in rat hepatocytes cultured on Matrigel. LPS caused the down-regulation of CYP2B1 mRNA to 20% of control values within 12 h of treatment, and this was not reversed by concentrations of NO synthase inhibitors that completely blocked NO production. LPS was several orders of magnitude more potent in the down-regulation of CYP2B1 mRNA than in induction of NO production. In contrast, concentrations of LPS in the 1 to 100 ng/ml range induced NO production and produced a rapid down-regulation of CYP2B1 protein to 30% and <5% of control at 6 and 24 h, respectively, that could be completely prevented both by inhibitors of NO synthase and by LY83583, which prevents NO synthase-2 induction. The blockade of CYP2B1 down-regulation by NO synthase inhibitors was reversed by arginine, and the NO donors S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine mimicked CYP2B1 protein suppression. Taken together, these experiments demonstrate two independent mechanisms of CYP2B1 down-regulation by LPS: a rapid, NO-dependent suppression of the protein occurring at high concentrations of LPS and a slower, NO-independent pretranslational suppression occurring at low concentrations of LPS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408616     DOI: 10.1124/mol.60.1.209

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.

Authors:  Choon-Myung Lee; Shweta Tripathi; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2017-04-17       Impact factor: 7.376

Review 2.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

3.  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Authors:  Edward T Morgan; Cene Skubic; Choon-Myung Lee; Kaja Blagotinšek Cokan; Damjana Rozman
Journal:  Drug Metab Rev       Date:  2020-09-08       Impact factor: 4.518

4.  Nitric oxide stimulates cellular degradation of human CYP51A1, the highly conserved lanosterol 14α-demethylase.

Authors:  Ji Won Park; Aria Byrd; Choon-Myung Lee; Edward T Morgan
Journal:  Biochem J       Date:  2017-09-14       Impact factor: 3.857

5.  Role of vascular reactive oxygen species in regulating cytochrome P450-4A enzyme expression in Dahl salt-sensitive rats.

Authors:  Kathleen M Lukaszewicz; Mahesh P Paudyal; John R Falck; Julian H Lombard
Journal:  Microcirculation       Date:  2016-10       Impact factor: 2.628

6.  Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.

Authors:  Choon-Myung Lee; Jan Pohl; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

7.  Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins.

Authors:  Choon-Myung Lee; Bong-Yoon Kim; Lian Li; Edward T Morgan
Journal:  J Biol Chem       Date:  2007-11-09       Impact factor: 5.157

8.  Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.

Authors:  Alison E Aitken; Choon-Myung Lee; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

9.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

Review 10.  Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression.

Authors:  Satyanarayana R Pondugula; Hanqing Dong; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-08       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.